Fingerprint
Dive into the research topics of 'Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically